Concentrum Wealth Management

Position in AMGN — Amgen Inc

CIK 1765387 SAN JOSE, CA

Position in AMGN

as of Jun 30, 2026 · filed Aug 6, 2026 Compact

Position Value

$707,582

+$17,956 QoQ

Shares Held

1,954

-0.3% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.24%

of 13F equity value

Holder Rank

#1,945

of 3,140 holders

Holding Since

Dec 2023

9 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Concentrum Wealth Management holds $3,763,659 across 6 Drug Manufacturers - General names. AMGN ranks #2 (18.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson	3,991	$1,013,594
2	AMGN	Amgen Inc This page	1,954	$707,582
3	GILD	Gilead Sciences, Inc.	5,333	$673,771
4	ABBV	AbbVie Inc.	2,422	$609,472
5	MRK	Merck & Co., Inc.	3,939	$506,161
6	LLY	ELI LILLY & Co	211	$253,079

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$707,582	1,954	-0.3%	Shares	Sole	2026-08-06
2026-03-31	$689,626	1,960	+126.6%	Shares	Sole	2026-05-04
2025-12-31	$283,123	865	+18.3%	Shares	Sole	2026-02-04
2025-09-30	$206,288	731	-2.9%	Shares	Sole	2025-11-10
2025-03-31	$234,597	753	+4.3%	Shares	Sole	2025-05-07
2024-09-30	$232,635	722	+1.1%	Shares	Sole	2024-11-13
2024-06-30	$223,089	714	-0.6%	Shares	Sole	2024-08-13
2024-03-31	$204,141	718	+3.0%	Shares	Sole	2024-05-06
2023-12-31	$200,749	697	—	Shares	Sole	2024-02-13
No filing history on record for this holder in this stock.